List of Antares Pharma Inc. patents

Patent 8376993 was granted and assigned to Antares Pharma Inc. on February, 2013 by the United States Patent and Trademark Office.

Patent 9364611 was granted and assigned to Antares Pharma Inc. on June, 2016 by the United States Patent and Trademark Office.

Patent 9446195 was granted and assigned to Antares Pharma Inc. on September, 2016 by the United States Patent and Trademark Office.

Patent 9364610 was granted and assigned to Antares Pharma Inc. on June, 2016 by the United States Patent and Trademark Office.

Patent 11446440 was granted and assigned to Antares Pharma Inc. on September, 2022 by the United States Patent and Trademark Office.

Patent 9561333 was granted and assigned to Antares Pharma Inc. on February, 2017 by the United States Patent and Trademark Office.

Patent 10279131 was granted and assigned to Antares Pharma Inc. on May, 2019 by the United States Patent and Trademark Office.

Patent 8480631 was granted and assigned to Antares Pharma Inc. on July, 2013 by the United States Patent and Trademark Office.

Patent 11185642 was granted and assigned to Antares Pharma Inc. on November, 2021 by the United States Patent and Trademark Office.

Patent 11291773 was granted and assigned to Antares Pharma Inc. on April, 2022 by the United States Patent and Trademark Office.

Patent 10905827 was granted and assigned to Antares Pharma Inc. on February, 2021 by the United States Patent and Trademark Office.

Patent 10013895 was granted and assigned to Antares Pharma Inc. on July, 2018 by the United States Patent and Trademark Office.

Patent 10300207 was granted and assigned to Antares Pharma Inc. on May, 2019 by the United States Patent and Trademark Office.

Patent 10357609 was granted and assigned to Antares Pharma Inc. on July, 2019 by the United States Patent and Trademark Office.

Patent 8162886 was granted and assigned to Antares Pharma Inc. on April, 2012 by the United States Patent and Trademark Office.

Patent 10124115 was granted and assigned to Antares Pharma Inc. on November, 2018 by the United States Patent and Trademark Office.

Patent 8696618 was granted and assigned to Antares Pharma Inc. on April, 2014 by the United States Patent and Trademark Office.

Patent 9744302 was granted and assigned to Antares Pharma Inc. on August, 2017 by the United States Patent and Trademark Office.

Patent 9789257 was granted and assigned to Antares Pharma Inc. on October, 2017 by the United States Patent and Trademark Office.

Patent 10589035 was granted and assigned to Antares Pharma Inc. on March, 2020 by the United States Patent and Trademark Office.

Patent 9333309 was granted and assigned to Antares Pharma Inc. on May, 2016 by the United States Patent and Trademark Office.

Patent 9808582 was granted and assigned to Antares Pharma Inc. on November, 2017 by the United States Patent and Trademark Office.

Patent 9737670 was granted and assigned to Antares Pharma Inc. on August, 2017 by the United States Patent and Trademark Office.

Patent 11471600 was granted and assigned to Antares Pharma Inc. on October, 2022 by the United States Patent and Trademark Office.

Patent 8419686 was granted and assigned to Antares Pharma Inc. on April, 2013 by the United States Patent and Trademark Office.